Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 394

ClinicalTrials.gov

Author's Posts:
Cervical Cancer Prevention for Black Adults
Condition:   Cervical Cancer
Intervention:   Behavioral: Health is Wealth: A Cervical Health Program
Sponsors:   AdegboyegaA;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2021 / by / in
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy
Conditions:   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage IA Breast Cancer AJCC v8;   Anatomic Stage IB Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage IIA Breast Cancer AJCC v8;   Anatomic Stage IIB Breast Cancer AJCC v8;   Anatomic Stage III Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Anatomic Stage IIIB Breast Cancer AJCC v8;   Anatomic Stage IIIC Breast Cancer AJCC v8;   Prognostic Stage I Breast Cancer AJCC v8;   Prognostic Stage IA Breast Cancer AJCC v8;   Prognostic Stage IB Breast Cancer AJCC v8;   Prognostic Stage II Breast Cancer AJCC v8;   Prognostic Stage IIA Breast Cancer AJCC v8;   Prognostic Stage IIB Breast Cancer AJCC v8;   Prognostic Stage III Breast Cancer AJCC v8;   Prognostic Stage IIIA Breast Cancer AJCC v8;   Prognostic Stage IIIB Breast Cancer AJCC v8;   Prognostic Stage IIIC Breast Cancer AJCC v8;   Stage I Prostate Cancer AJCC v8;   Stage II Prostate Cancer AJCC v8;   Stage IIA Prostate Cancer AJCC v8;   Stage IIB Prostate Cancer AJCC v8;   Stage IIC Prostate Cancer AJCC v8;   Stage III Prostate Cancer AJCC v8;   Stage IIIA Prostate Cancer AJCC v8;   Stage IIIB Prostate Cancer AJCC v8;   Stage IIIC Prostate Cancer AJCC v8;   Stage IVA Prostate Cancer AJCC v8
Intervention:   Other: Survey Administration
Sponsors:   University of Southern California;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2021 / by / in
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
Conditions:   Primary Extra-cranial Solid Tumor;   Recurrent or Refractory Glypican 3 (GPC3)
Intervention:   Drug: Codrituzumab
Sponsors:   Memorial Sloan Kettering Cancer Center;   Chugai Pharma USA
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2021 / by / in
Motivating a Spectrum of Cancer Patients to Quit Smoking
Conditions:   Cancer;   Smoking
Intervention:   Behavioral: Self-help Materials
Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2021 / by / in
Napoleon Measurement of Gastrojejunal Anastomosis
Conditions:   Gastric Bypass;   Weight Regain
Interventions:   Device: Napoleon;   Other: Visual estimation
Sponsors:   NYU Langone Health;   Brigham and Women’s Hospital
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 16, 2021 / by / in
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Conditions:   Low-Grade Glioma;   Recurrent Low-Grade Glioma;   Progressive Low-Grade Glioma
Intervention:   Drug: Mirdametinib
Sponsors:   St. Jude Children’s Research Hospital;   SpringWorks Therapeutics, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 16, 2021 / by / in
ConMed Beamer Study
Conditions:   Gastrointestinal Neoplasms;   Achalasia;   Gastroparesis
Intervention:  
Sponsors:   Baylor College of Medicine;   ConMed Corporation
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2021 / by / in
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab in Participants With Advanced Solid Tumors
Conditions:   Cervical Cancer;   Gastric/Gastroesophageal Junction Adenocarcinoma;   Microsatellite Stable Colorectal Cancer;   Non-Small-Cell Lung Cancer;   Squamous Cell Carcinoma of Head and Neck
Interventions:   Drug: BMS-986340;   Drug: BMS-936558-01
Sponsor:   Bristol-Myers Squibb
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2021 / by / in
Localized Leiomyosarcoma Biomarker Protocol
Condition:   Leiomyosarcoma
Intervention:   Other: Blood and Tissue collection
Sponsor:   Sarcoma Alliance for Research through Collaboration
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2021 / by / in
Study of XB002 in Subjects With Solid Tumors
Conditions:   Non Small Cell Lung Cancer;   Urothelial Cancer;   Epithelial Ovarian Cancer;   Cervical Cancer;   SCCHN;   Pancreatic Cancer
Intervention:   Drug: XB002
Sponsor:   Exelixis
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2021 / by / in